Substituted oxazolidine calpain and/or cathepsin b inhibitors
CA 2210258 C · Owner: Aventis Pharmaceuticals Inc. · Inventors: Mehdi, Shujaath; Kim, Hwa-Ok; Peet, Norton P.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This invention relates to oxazolidine inhibitors of calpain and/or cathepsin B and to compositions containing them, having the general formula:, (See formula I) As inhibitors of calpain and/or cathepsin B the compounds, are useful in the treatment of patients afflicted with acute or chronic neurodegenerative disorders.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 15, 1995 and granted October 1, 2002. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended December 15, 2015.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 15, 2017.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.